Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.
Published August 10, 2022 · Recall initiated: July 21, 2022
Summary
FDA records drug Class II recall D-1302-2022, published August 10, 2022 and initiated July 21, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 8022 bottles; Lot: Lot 1411593A, Exp 09/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: below specification limits for dissolution.
What to do
Voluntary: Firm initiated
Get an email if MATZIM LA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MATZIM LA
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 1411593A, Exp 09/22
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANaftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48), b) NetAugust 10, 2022
- FDAMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, ManufacturedAugust 10, 2022
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDACobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D)August 3, 2022
- FDAMedline Convenience kits labeled as follows: a. BEDSIDE PICC CDS, Model Number CDS984642, b. VASCULAR CDS,August 3, 2022
- FDAMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, ManufacturedOctober 16, 2019
Questions about this recall
Was Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30. recalled?
Yes. FDA published recall D-1302-2022 on August 10, 2022. Reported hazard: Failed Dissolution Specifications: below specification limits for dissolution.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MATZIM LA.